Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-24-001575
Filing Date
2024-07-16
Accepted
2024-07-16 18:06:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da112208003_07162024.htm SC 13D/A 103660
  Complete submission text file 0000921895-24-001575.txt   105262
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Subject) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91001 | Film No.: 241120597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1500 BROADWAY SUITE 704 NEW YORK NY 10036
Business Address 1500 BROADWAY SUITE 704 NEW YORK NY 10036 2123191778
Alta Fundamental Advisers LLC (Filed by) CIK: 0001641604 (see all company filings)

EIN.: 461788509 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A